As shown in Figure 2, primary MR analysis by the IVW method showed that circulating levels of FGF23 affected the risk of MS (OR = 0.63; 95% CI, 0.49-0.82; p = 4.7 × 10-4). Here, FGF23 is linked to myeloid sarcoma.